GS
GILEAD SCIENCES INC
GILD· Health Care· BiotechnologyS&P 500
Close · 10/09/2026
144.81
1D
-0.58%52-week range
108.46 – 157.29
Volume
60,19,300.00
Price history
GILD
11/08/2026 to 10/09/2026
O 145.07 H 145.91 L 143.67
1W-3.21%
1M+6.66%
3M+19.20%
6M-0.82%
1Y+25.10%
3Y+92.67%
5Y+101.49%
MAX+113.93%
Fundamentals
as of 10/09/2026- Market cap
- $179.56B
- Shares out
- 1.24B
- P/E (forward)
- 15.27
- EPS (trailing)
- -2.61
- Dividend yield
- 2.22%
- Beta
- 0.35
- Profit margin
- -10.64%
- P/B
- 15.18
- Return on equity
- -27.39%
SEC financial statements
67 quarterly and 19 annual periods through 30/06/2026.
Details
- Ticker
- GILD
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
11 filers · 2 on watchlist · 22 buys · 10 sells · 7 options · ?: 3 · D: 11 · R: 18
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 08/05/2024Thomas H TubervilleWSellGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 06/05/2026Jared MoskowitzBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 06/05/2026Jared MoskowitzBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 27/01/2026Josh GottheimerWBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000